Skip to main content
Fig. 2 | Respiratory Research

Fig. 2

From: Effect of smoking status on lung function, patient-reported outcomes, and safety among COPD patients treated with glycopyrrolate inhalation powder: pooled analysis of GEM1 and GEM2 studies

Fig. 2

Pooled analysis of a SGRQ total score and b CAT score at Week 12 by smoking status (FAS). *P < 0.05, ***P < 0.001 vs placebo; †P < 0.05 vs smoker. CAT, COPD Assessment Test; FAS, full analysis set; GLY, glycopyrrolate; LSM, least squares mean; SE, standard error; SGRQ, St George’s Respiratory Questionnaire

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us